Company profile
Immutrin
Next Generation Antibody Therapy for Reversal of Amyloidosis
- Industry
- Biotechnology Research
- Employees
- 16
- Headquarters
- Cambridge
- Office locations
- 2
Immutrin company summary
Immutrin is a company in the Biotechnology Research industry, headquartered in Cambridge. On LinkedIn the company has around 16 employees. The company lists 2 office locations.
What technology does Immutrin use?
No technologies detected yet. Warmrank rechecks company websites on a rolling basis.
About Immutrin
Immutrin is a biotechnology company developing next generation antibody therapy to deplete systemic amyloid deposits and reverse amyloidosis. The Company’s lead asset is being developed for the treatment of ATTR cardiomyopathy, a serious and progressive form of amyloidosis. Immutrin's antibody is a potential best-in-class therapy, with a unique mechanism of action designed to selectively and exclusively remove established amyloid fibrils.
Where is Immutrin located?
Immutrin lists 2 office locations.
Compare companies similar to Immutrin
More companies in Biotechnology Research.
| Company | Industry | Employees | Founded | Headquarters |
|---|---|---|---|---|
Immutrin immutrin.com | Biotechnology Research | 16 | - | Cambridge |
 Thermo Fisher Scientific thermofisher.com | Biotechnology Research | 100,779 | - | Waltham, MA |
 Amgen amgen.com | Biotechnology Research | 41,028 | 1980 | Thousand Oaks, CA |
 Biogen biogen.com | Biotechnology Research | 7,742 | - | Cambridge, MA |
 Biocon biocon.com | Biotechnology Research | 11,902 | - | Bangalore, Karnataka |
| Biotechnology Research | 28,679 | - | Bethesda, MD | |
 Genentech gene.com | Biotechnology Research | 18,296 | 1976 | South San Francisco, California |
 Eurofins eurofins.com | Biotechnology Research | 24,928 | - | Luxembourg, Luxembourg |
 Gilead Sciences gilead.com | Biotechnology Research | 14,743 | - | Foster City, CA |
 Syneos Health syneoshealth.com | Biotechnology Research | 23,772 | - | Morrisville, NC |
 Moderna modernatx.com | Biotechnology Research | 6,238 | 2010 | Cambridge, Massachusetts |
Frequently asked questions about Immutrin
What does Immutrin do?
Immutrin is a biotechnology company developing next generation antibody therapy to deplete systemic amyloid deposits and reverse amyloidosis. The Company’s lead asset is being developed for the treatment of ATTR cardiomyopathy, a serious and progressive form of amyloidosis. Immutrin's antibody is a potential best-in-class therapy, with a unique mechanism of action designed to selectively and exclusively remove established amyloid fibrils.
How many employees does Immutrin have?
Immutrin has around 16 employees on LinkedIn.
Where is Immutrin headquartered?
Immutrin is headquartered in Cambridge.
Where does Immutrin have offices?
Immutrin lists 2 office locations, including Cambridge, GB, GB.
Build a lead list from companies like Immutrin
Describe your ICP or import a CSV. Warmrank finds matching companies, enriches contacts with verified emails, and tracks every lead.